Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
PUT
Kohl's
KSS
$2.19B
| $2.52M | ﹤0.01% |
+100,000
| New | +$2.83M |
|
2052
NorthWestern Energy
NWE
$4.43B
| $2.52M | ﹤0.01% |
42,546
+1,870
| +5% | +$102K |
|
|
BNR
2053
Burning Rock Biotech
BNR
$92.9M
| $2.51M | ﹤0.01% |
111,689
-22,849
| -17% | -$521K |
|
2054
Terex
TEX
$7.74B
| $2.51M | ﹤0.01% |
58,729
+4,859
| +9% | +$196K |
|
|
RPT
2055
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $2.5M | ﹤0.01% |
249,343
-15,716
| -6% | -$155K |
|
2056
Madison Square Garden
MSGS
$9.39B
| $2.5M | ﹤0.01% |
13,629
+1,406
| +12% | +$221K |
|
2057
National Vision
EYE
$1.81B
| $2.49M | ﹤0.01% |
64,368
-2,899
| -4% | -$109K |
|
2058
Ligand Pharmaceuticals
LGND
$5.88B
| $2.49M | ﹤0.01% |
37,323
-7,197
| -16% | -$468K |
|
2059
CALL
LyondellBasell Industries
LYB
$19.2B
| $2.49M | ﹤0.01% |
+30,000
| New | +$2.46M |
|
|
2060
PUT
LyondellBasell Industries
LYB
$19.2B
| $2.49M | ﹤0.01% |
+30,000
| New | +$2.46M |
|
2061
Hanover Insurance
THG
$7.98B
| $2.49M | ﹤0.01% |
18,412
+1,228
| +7% | +$171K |
|
2062
PUT
Prudential Financial
PRU
$41.8B
| $2.49M | ﹤0.01% |
25,000
-5,600
| -18% | -$567K |
|
2063
Genpact
G
$5.81B
| $2.48M | ﹤0.01% |
53,621
+641
| +1% | +$29.1K |
|
2064
Ameris Bancorp
ABCB
$5.89B
| $2.48M | ﹤0.01% |
52,596
+763
| +1% | +$38.2K |
|
2065
ICU Medical
ICUI
$4.61B
| $2.48M | ﹤0.01% |
15,719
-36,185
| -70% | -$5.51M |
|
2066
Douglas Emmett
DEI
$1.96B
| $2.47M | ﹤0.01% |
157,613
+80,299
| +104% | +$1.34M |
|
|
TTM
2067
DELISTED
Tata Motors Limited
TTM
| $2.47M | ﹤0.01% |
106,830
-69,752
| -40% | -$1.75M |
|
2068
Woodward
WWD
$21.4B
| $2.47M | ﹤0.01% |
25,543
+691
| +3% | +$63.9K |
|
|
MPT
2069
PUT
Medical Properties Trust
MPT
$2.81B
| $2.46M | ﹤0.01% |
+221,200
| New | +$2.57M |
|
|
CSGS
2070
DELISTED
CSG Systems International
CSGS
| $2.46M | ﹤0.01% |
42,940
+4,282
| +11% | +$252K |
|
2071
Leggett & Platt
LEG
$1.31B
| $2.45M | ﹤0.01% |
76,112
+22,010
| +41% | +$741K |
|
2072
Independent Bank
INDB
$3.99B
| $2.45M | ﹤0.01% |
29,029
+10,936
| +60% | +$927K |
|
|
USCT
2073
DELISTED
Roth CH Acquisition Co. Class A Ordinary Shares
USCT
| $2.45M | ﹤0.01% |
237,948
-150,000
| -39% | -$1.54M |
|
2074
AXIS Capital
AXS
$7.55B
| $2.45M | ﹤0.01% |
45,166
-22,224
| -33% | -$1.2M |
|
2075
Aehr Test Systems
AEHR
$3.36B
| $2.44M | ﹤0.01% |
121,601
+120,377
| +9,835% | +$2.58M |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.